Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Public Health Service Guidelines for the Management of Possible Sexual, Injecting-Drug-Use, or Other Nonoccupational Exposure to HIV, Including Considerations Related to Antiretroviral Therapy

September 25, 1998

Contributors


The following CDC staff members prepared this report:

Dawn K. Smith, M.D., M.S., M.P.H.
Robert S. Janssen, M.D.
David R. Holtgrave, Ph.D.
Kevin M. De Cock, M.D., D.T.M.&H.
Division of HIV/AIDS Prevention -- Surveillance and Epidemiology National Center for HIV, STD, and TB Prevention

in collaboration with

Advertisement
Eric P. Goosby, M.D.
US Department of Health and Human Services

Roberta J. Black, Ph.D.
Henry L. Francis, M. D.
Rodney Hoff, D.Sc., M.P.H.
National Institutes of Health

Kimberly A. Struble
R. Douglas Pratt, M.D., M.P.H.
Food and Drug Administration

Debra L. Parham, Ph.D.
Health Resources and Services Administration


Back | Next
Table of Contents




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication Morbidity and Mortality Weekly Report. Visit the CDC's website to find out more about their activities, publications and services.
 

Tools
 

Advertisement